EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sleep Disturbance at Cancer Diagnosis and Its Associations With Depressive Symptoms and Systemic Inflammatory Burden

Zeynep Gülsüm Güç iD, Hüseyin Döngelli iD, Hasan Güç iD, Ahmet Alacacıoğlu iD, Mustafa Oktay Tarhan iD

Psycho-Oncology · 2026

DOI: 10.1002/pon.70576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psycho-Oncology, 2026. Verfasst von Zeynep Gülsüm Güç und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Atatürk Training and Research Hospital, İzmir Katip Çelebi University, İzmir, Türkiye. Hauptthemen laut MEDLINE: Depression, Neoplasms, Sleep Wake Disorders, Inflammation. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sleep disturbance is highly prevalent among cancer patients and closely associated with depressive symptoms. However, it remains unclear whether sleep problems present at cancer diagnosis primarily reflect depression or also indicate an underlying biological susceptibility.

Aim

This study aimed to examine the relationships between sleep disturbance, depressive symptoms, and systemic inflammatory–nutritional burden in newly diagnosed, treatment‐naïve cancer patients.

Methods

In this cross‐sectional study, sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI) in patients at diagnosis before oncological treatment. Poor sleep quality (PSQ) was defined as PSQI ≥ 5, and sleep disturbance severity was evaluated using the total PSQI score. Depressive symptoms were measured with the Hospital Anxiety and Depression Scale–Depression subscale (HADS‐D). Systemic inflammatory indices, including neutrophil‐to‐lymphocyte ratio (NLR) and lactate dehydrogenase–to‐albumin ratio (LAR), were calculated from routine laboratory data. Multivariable logistic regression and generalized linear models assessed factors associated with PSQ and sleep disturbance severity, respectively. Receiver operating characteristics (ROC) analyses evaluated the discriminatory performance of depressive symptoms and inflammatory indices. Stratified analyses were conducted according to depression status (HADS‐D < 8 vs. ≥ 8).

Results

Sleep disturbance was highly prevalent at diagnosis. Depressive symptom burden was independently associated with both PSQ and higher PSQI scores. Importantly, systemic inflammatory indices remained independently associated with sleep disturbance after adjustment for depressive symptoms and clinical variables. NLR showed moderate discriminatory ability for PSQ, while LAR was independently associated with sleep disturbance severity. ROC analyses indicated that depressive symptoms and inflammatory burden jointly improved discrimination of PSQ. In stratified analyses, LAR remained significantly associated with PSQI scores regardless of depression status.

Conclusion

Sleep disturbance at cancer diagnosis is independently associated with both depressive symptoms and systemic inflammatory–nutritional burden, suggesting that it may reflect not only psychological distress but also underlying biological processes. Routine sleep assessment alongside inflammatory markers may help identify vulnerable patients and support early supportive care planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DepressionNeoplasmsSleep Wake DisordersInflammationHumansMaleFemaleCross-Sectional StudiesMiddle AgedAgedSleep QualitySeverity of Illness IndexAdultNeutrophilsPrevalenceSymptom BurdenL-Lactate Dehydrogenase

Stichwörter der Autor:innen

cancer diagnosisdepressioninflammatory biomarkerspsycho‐oncologysleep disturbancesystemic inflammation

Substanzen

L-Lactate Dehydrogenase

Autor:innen und Institutionen

  • Department of Medical Oncology, Atatürk Training and Research Hospital, İzmir Katip Çelebi University, İzmir, Türkiye.
  • Department of Internal Medicine, Buca Seyfi Demirsoy Training and Research Hospital, İzmir, Türkiye.
  • Department of Plastic, Reconstructive and Aesthetic Surgery, İzmir Tepecik Training and Research Hospital, İzmir, Türkiye.
  • Department of Medical Oncology, Institute of Oncology, Dokuz Eylül University, İzmir, Türkiye.

ORCID-Profile: Zeynep Gülsüm Güç, Hüseyin Döngelli, Hasan Güç, Ahmet Alacacıoğlu, Mustafa Oktay Tarhan

Zitieren

APA

Güç, Z. G., Döngelli, H., Güç, H., Alacacıoğlu, A., & Tarhan, M. O. (2026). Sleep Disturbance at Cancer Diagnosis and Its Associations With Depressive Symptoms and Systemic Inflammatory Burden. Psycho-Oncology. https://doi.org/10.1002/pon.70576

Vancouver

Güç ZG, Döngelli H, Güç H, Alacacıoğlu A, Tarhan MO. Sleep Disturbance at Cancer Diagnosis and Its Associations With Depressive Symptoms and Systemic Inflammatory Burden. Psycho-Oncology. 2026. doi:10.1002/pon.70576

BibTeX
@article{G2026,
  author = {Güç, Zeynep Gülsüm and Döngelli, Hüseyin and Güç, Hasan and Alacacıoğlu, Ahmet and Tarhan, Mustafa Oktay},
  title = {Sleep Disturbance at Cancer Diagnosis and Its Associations With Depressive Symptoms and Systemic Inflammatory Burden},
  journal = {Psycho-Oncology},
  year = {2026},
  doi = {10.1002/pon.70576}
}
Kostenlos starten →